Early combination therapy of COVID-19 in high-risk patients
HM Orth, C Flasshove, M Berger, T Hattenhauer… - Infection, 2024 - Springer
Purpose Prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has been observed in immunocompromised hosts. Early monotherapy with direct …
CoV-2) has been observed in immunocompromised hosts. Early monotherapy with direct …
[HTML][HTML] Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
G Rossi, J Salmanton-García, C Cattaneo… - International Journal of …, 2023 - Elsevier
Objectives Elderly patients with hematologic malignancies face the highest risk of severe
COVID-19 outcomes. The infection's impact on different age groups remains unstudied in …
COVID-19 outcomes. The infection's impact on different age groups remains unstudied in …
[HTML][HTML] Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
J Salmanton-García, F Marchesi, F Farina… - …, 2024 - thelancet.com
Background The COVID-19 pandemic heightened risks for individuals with hematological
malignancies due to compromised immune systems, leading to more severe outcomes and …
malignancies due to compromised immune systems, leading to more severe outcomes and …
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Study objectives This study aimed to achieve several key objectives related to patients with
haematological malignancies and COVID-19 who required ICU admission. Firstly, we …
haematological malignancies and COVID-19 who required ICU admission. Firstly, we …